Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03675412
NA

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Sponsor: Wills Eye

View on ClinicalTrials.gov

Summary

Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.

Official title: Acute Changes in Optic Nerve Head (ONH) and Macular Blood Flow After Caffeine Consumption in Glaucoma Patients and Healthy Subjects: A Quantitative Optic Coherence Tomography Angiography (OCTA) Study

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2018-12-30

Completion Date

2026-12-31

Last Updated

2025-11-14

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Caffeine tablet

Each eligible participant will receive one 200 mg caffeine tablet to ingest after completing all baseline study tasks.

Locations (1)

Wills Eye Glaucoma Service

Philadelphia, Pennsylvania, United States